Alger Jason 4

What Happened

Jason Alger, Chief Financial Officer of Health Catalyst, sold 18,804 shares on 2026-06-01 at $1.37 per share, for proceeds of $25,765. The sale was a "sell-to-cover" tied to the vesting of restricted stock units (RSUs) to satisfy tax withholding obligations rather than a discretionary open-market sale.

Key Details

• Transaction date: 2026-06-01; Form 4 filed 2026-06-03 (timely within the 2-business-day filing window).
• Shares disposed: 18,804 at $1.37 each; total proceeds $25,765.
• Shares owned after transaction: Not specified in the filing.
• Footnote: F1 — shares were sold to cover tax withholding on vested RSUs as required by the issuer's equity plan; this was not a discretionary trade.
• Transaction code: F (payment of exercise price or tax liability / tax withholding).

Context

This was a routine sell-to-cover following RSU vesting, commonly used by companies to satisfy payroll tax withholding and does not necessarily indicate the insider's view of the company's prospects. The filing shows no option exercise or separate open-market sale—just the mandated withholding sale of vested shares.